Synchron is backed by major investors like Jeff Bezos and Bill Gates, to whom we owe Amazon and Microsoft respectively. The company is seeking its first patient volunteers, according to recent information, with the aim of carrying out a large-scale clinical trial.
In total, the 120 test centers will welcome several dozen volunteers who suffer from motor problems. We are talking about people who have suffered a stroke or suffer from various forms of multiple sclerosis.
Synchro is still waiting for the green light from the Food and Drug Administration (FDA) to launch its large-scale trials after a preliminary phase validated in 2021. During this period, six people affected by severe paralysis were implanted. The implant market, despite the reluctance of the authorities, is becoming more and more talked about while many investors are injecting crazy sums into these start-ups.